A Prospective Study of Higher Neural Control Changes Following Intradetrusor Injection of BotulinumtoxinA in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.

Trial Profile

A Prospective Study of Higher Neural Control Changes Following Intradetrusor Injection of BotulinumtoxinA in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Neurogenic bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Apr 2018 Status changed from active, no longer recruiting to recruiting.
    • 03 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top